Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy

Clinical trial NCT07227285 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07227285
Sponsor: Cyllene Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urinary Bladder, Overactive Spinal Cord Injury

Start date: 2026-04-01
Primary completion: 2031-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.